| 注册
首页|期刊导航|中国现代医学杂志|五味子乙素抗肾纤维化作用及机制研究

五味子乙素抗肾纤维化作用及机制研究

郑海洲 张杰 肖程程 秦聪 徐涛

中国现代医学杂志2017,Vol.27Issue(27):1-6,6.
中国现代医学杂志2017,Vol.27Issue(27):1-6,6.DOI:10.3969/j.issn.1005-8982.2017.27.001

五味子乙素抗肾纤维化作用及机制研究

Protective effect of Schisandrin B on renal fibrosis and underlying mechanism

郑海洲 1张杰 1肖程程 1秦聪 1徐涛1

作者信息

  • 1. 武汉大学人民医院 泌尿外科,湖北 武汉 430060
  • 折叠

摘要

Abstract

Objective To investigate the protective of Schisandrin (Sch B) on renal fibrosis and underlying mechanism. Methods Mice were subjected to ischemia-reperfusion (I/R) injury in presence or absence of Sch B. Masson staining was performed for morphological grading of renal fibrosis. α-SMA and Collagen I expression in kidney tissue were determined by Immunohistochemistry. The expression levels of α-SMA, collagenⅠ, E-cadherin, transforming growth factor β1 (TGF-β1) and p-Smad3 were measured by Western blot. Results Renal fibrosis and tubular atrophy were significantly alleviated by Sch B treatment when compared with I/R group. Immunohistochemistry staining showed that α-SMA and Collagen I in the I/R group increased significantly, which was attenuated by Sch B. Western blot suggested that, in the Sch B group, the expression of E-cadherin was increased while α-SMA, Collagen I, TGF-β1 and p-Smad3 decreased dramatically in a dose dependent manner in comparison with those in the I/R group. Conclusions Data confirms that SchB can ameliorate renal fibrosis by inhibiting TGF-β/Smad signaling pathway, which could be a potential therapeutic intervention for renal fibrosis.

关键词

肾纤维化/五味子乙素/缺血再灌注/治疗

Key words

renal fibrosis/Schisandrin B/ischemia reperfusion

分类

医药卫生

引用本文复制引用

郑海洲,张杰,肖程程,秦聪,徐涛..五味子乙素抗肾纤维化作用及机制研究[J].中国现代医学杂志,2017,27(27):1-6,6.

基金项目

国家自然科学基金(No:81470923) (No:81470923)

中国现代医学杂志

OACSTPCD

1005-8982

访问量0
|
下载量0
段落导航相关论文